WO1995029996A1 - Alkaline glucose oxidase - Google Patents

Alkaline glucose oxidase Download PDF

Info

Publication number
WO1995029996A1
WO1995029996A1 PCT/DK1995/000178 DK9500178W WO9529996A1 WO 1995029996 A1 WO1995029996 A1 WO 1995029996A1 DK 9500178 W DK9500178 W DK 9500178W WO 9529996 A1 WO9529996 A1 WO 9529996A1
Authority
WO
WIPO (PCT)
Prior art keywords
glucose oxidase
dough
glucose
strain
detergent composition
Prior art date
Application number
PCT/DK1995/000178
Other languages
French (fr)
Inventor
Karen M. OXENBØLL
Joan Qi Si
Jesper Aagaard
Original Assignee
Novo Nordisk A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S filed Critical Novo Nordisk A/S
Priority to EP95918541A priority Critical patent/EP0758377A1/en
Priority to AU24450/95A priority patent/AU695391B2/en
Priority to US08/446,645 priority patent/US5741688A/en
Publication of WO1995029996A1 publication Critical patent/WO1995029996A1/en
Priority to US08/746,283 priority patent/US5834280A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0006Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D8/00Methods for preparing or baking dough
    • A21D8/02Methods for preparing dough; Treating dough prior to baking
    • A21D8/04Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/042Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16Organic compounds
    • C11D3/38Products with no well-defined composition, e.g. natural products
    • C11D3/386Preparations containing enzymes, e.g. protease or amylase
    • C11D3/38654Preparations containing enzymes, e.g. protease or amylase containing oxidase or reductase

Definitions

  • the present invention relates to a novel glucose oxidase, to a process for its production and to its use in bleaching and detergent compositions, as well as to its use as a dough strengthener.
  • Glucose oxidases are enzymes that catalyze the oxidation of glucose with oxygen whereby hydrogen peroxide is formed. Such enzymes are known from microbial, plant and animal origins, e.g., glucose oxidase from Aspergillus, Penicillium and Talaromyces. Glucose oxidase has been described as useful for various purposes, e.g., for bleaching purposes and in the baking industry, useful for strengthening the dough.
  • GluzymeTM an Aspergillus niger glucose oxidase, available from Novo Nordisk A/S. This and similar products from other commercial sources have an acidic pH optimum, typically around pH 5, which means that they are not very active in detergent solu ⁇ tions due to the alkaline character of the detergents.
  • the present invention relates to a glucose oxidase characterized by a pH-optimum in the range pH 6-7, having more than 75% of maximum activity at pH 8, deter mined at 30°C with D-glucose as substrate.
  • Fig. 1 shows the relation between pH and the glucose oxidase activity of a novel glucose oxidase according to the invention (the glucose oxidase obtained according to Example 1), with D-glucose as substrate in the presence of oxygen at 30°C, using a buffer system adjusted to predetermined pH values of from pH 4 to pH 9.
  • Fig. 2 shows the dynamic shear storage modulus G' in gluten from 4 different doughs characterized with the following symbols:
  • a dough containing 20 ppm KBrO 3 .
  • a dough containing 500 UNITS per kg of flour of a glucose oxidase from A. niger.
  • a dough containing 500 UNITS per kg of flour of a glucose oxidase of the invention, obtained as described in Example 1.
  • Fig. 3 shows the viscoelastic phase angle ⁇ in gluten from 4 different doughs characterized with the following symbols:
  • a dough containing 500 UNITS per kg of flour of a glucose oxidase of the invention, obtained as described in Example 1.
  • glucose oxidase is obtainable from a glucose oxidase producing strain of Clado sporium, preferably Cladosporium oxysporum.
  • Cladosporium The genus Cladosporium is characterized primarily by the formation of conidia in branching chains, which are very fragile and readily break up into units.
  • the conidia can be either hyaline or pigmented, smooth or roughened, continuous or septate.
  • the conidiophores are erect and pigmented, branching irregularly at the apex. Cladosporium oxysporum is further described by M. B. Ellis in Dermatiaceous Hyphomycetes, 1971, p. 312, CAB International, UK.
  • Glucose oxidase of the invention may be produced by aerobic cultivation of the above mentioned microbial strain on a nutrient medium containing suitable carbon and nitrogen sources, such media being known in the art.
  • a temperature in the range of from 20°C to 30°C is suitable for growth and glucose oxidase production.
  • glucose oxidase of the invention can be produced by aerobic cultivation of a transformed host organism containing the appropriate genetic information from the above mentioned strain.
  • Such transformants can be prepared and cultivated by methods known in the art:
  • the DNA sequence encoding a glucose oxidase of the invention may be isolated from any cell or microorganism producing the glucose oxidase in question, using various methods well known in the art.
  • a genomic DNA and/or cDNA library should be constructed using chromosomal DNA or messenger RNA from the organism that produces the glucose oxidase to be studied.
  • homologous, labelled oligonucleotide probes may be synthesized and used to identify glucose oxidase- encoding clones from a genomic library prepared from the organism in question.
  • a labelled oligonucleotide probe containing sequences homologous to a known glucose oxidase gene could be used as a probe to identify glucose oxidase-encoding clones, using hybridization and washing conditions of lower stringency.
  • preferred probes may be constructed on the basis of SEQ ID No. 1.
  • Yet another method for identifying glucose oxidase-encoding clones would involve inserting fragments of genomic DNA into an expression vector, such as a plasmid, transforming glucose oxidase-negative bacteria with the resulting genomic DNA library, and then plating the transformed bacteria onto agar containing a substrate for glucose oxidase thereby allowing clones expressing the glucose oxidase to be identified.
  • an expression vector such as a plasmid
  • transforming glucose oxidase-negative bacteria with the resulting genomic DNA library
  • the DNA sequence encoding the enzyme may be prepared synthetically by established standard methods, e.g. the phosphoamidite method described by S.L. Beaucage and M.H. Caruthers in Tetrahedron Letters 22, 1981, pp. 1859-1869 or the method described by Matthes et al. in The EMBO J. 3, 1984, pp. 801-805.
  • phosphoamidite method oligonucleotides are synthesized, e.g. in an automatic DNA synthesizer, purified, annealed, ligated and cloned in appropriate vectors.
  • the DNA sequence may be of mixed genomic and synthetic origin, mixed synthetic and cDNA origin or mixed genomic and cDNA origin, prepared by ligating fragments of synthetic, genomic or cDNA origin (as appropriate, the fragments corresponding to various parts of the entire DNA sequence), in accordance with standard techniques.
  • the DNA sequence may also be prepared by polymerase chain reaction (PCR) using specific primers, for instance as described in US 4,683,202 or R.K. Saiki et al. in Science 239, 1988, pp. 487- 491 ,
  • a glucose oxidase-encoding DNA sequence produced by methods described above, or by any alternative methods known in the art can be expressed, in enzyme form, using an expression vector which typically includes control sequences encoding a promoter, operator, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes.
  • the recombinant expression vector carrying the DNA sequence encoding a glucose oxidase of the invention may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced.
  • the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g., a plasmid, a bacteriophage or an extrachromosomal element, minichromosome or an artificial chromosome.
  • the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome (s) into which it has been integrated.
  • the DNA sequence should be operably connected to a suitable promoter sequence.
  • the promoter may be any DNA sequence which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell.
  • suitable promoters for directing the transcription of the DNA sequence encoding a glucose oxidase of the inven ⁇ tion, especially in a bacterial host are the promoter of the lac operon of E.coli, the Streptomyces coelicolor agarase gene dagA promoters, the promoters of the Bacillus licheniformis ⁇ -amylase gene (amyL), the promoters of the Bacillus stearothermophilus maltogenic amylase gene (amyM), the promoters of the Bacillus Amyloliquefaciens ⁇ -amylase (amyO), the promoters of the Bacillus subtilis xylA and xylB genes etc.
  • examples of useful promoters are those derived from the gene encoding A. oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, A. niger neutral ⁇ -amylase, A. niger acid stable ⁇ -amylase, A. niger glucoamylase, Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase or A. nidulans acetamidase.
  • the expression vector of the invention may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably connected to the DNA sequence encoding the glucose oxidase of the invention. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.
  • the vector may further comprise a DNA sequence enabling the vector to replicate in the host cell in question.
  • a DNA sequence enabling the vector to replicate in the host cell in question. Examples of such sequences are the origins of replication of plasmids pUC19, pACYC177, pUB110, pE194, pAMB1 and pIJ702.
  • the vector may also comprise a selectable marker, e.g., a gene the product of which complements a defect in the host cell, such as the dal genes from B. subtilis or B. licheniformis, or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracyclin resistance.
  • a selectable marker e.g., a gene the product of which complements a defect in the host cell, such as the dal genes from B. subtilis or B. licheniformis, or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracyclin resistance.
  • the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and sC, a marker giving rise to hygromycin resistance, or the selection may be accomplished by co-transformation, e.g., as described in WO 91/17243.
  • intracellular expression may be advantageous in some respects, e.g., when using certain bacteria as host cells, it is generally preferred that the expression is extracellular.
  • the cell of the invention is advantageously used as a host cell in the recombinant production of a glucose oxidase of the invention.
  • the cell may be transformed with the DNA construct of the invention encoding the glucose oxidase conveniently by integrating the DNA construct (in one or more copies) in the host chromosome. This integration is generally considered to be an advantage as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g., by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.
  • the cell of the invention may be a cell of a higher organism such as a mammal or an insect, but is preferably a microbial cell, e.g., a bacterial or a fungal (including yeast) cell.
  • a microbial cell e.g., a bacterial or a fungal (including yeast) cell.
  • suitable bacteria are grampositive bacteria such as Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautus, Bacillusmegaterium, Bacillus thuringiensis, or Streptomyces lividans or
  • Streptomyces murinus or gramnegative bacteria such as E.coli.
  • the transformation of the bacteria may, for instance, be effected by protoplast transformation or by using competent cells in a manner known per se.
  • the yeast organism may favourably be selected from a species of Saccharomyces or Schizosaccharomyces, e.g., Saccharomyces cerevisiae.
  • the filamentous fungus may advantageously belong to a species of Aspergillus, e.g., Aspergillus oryzae or Aspergillus niger.
  • Fungal cells may be transformed bya process involving protoplast formation and transformation of the protoplasts followed by regeneration of the cell wall in a manner known per se. A suitable procedure for transformation of Aspergillus host cells is described in EP 238 023.
  • the present invention relates to a method of producing a glucose oxidase of the invention, which method comprises cultivating a host cell as described above under conditions conducive to the production of the glucose oxidase and recovering the glucose oxidase from the cells and/or culture medium.
  • the medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of the glucose oxidase of the invention. Suitable media are available from commercial suppliers or may be prepared according to published recipes (e.g., as described in catalogues of the American Type Culture Collection).
  • the glucose oxidase secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulphate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
  • Glucose oxidase activity is determined in the following way: Glucose oxidase oxidizes D-glucose in the presence of oxygen producing hydrogen peroxide. The hydrogen peroxide formed, in the presence of peroxidase, oxidizes ABTS
  • the glucose oxidase of the invention (obtained according to Example 1) possesses the following property:
  • the assay for glucose oxidase activity described above was run in a buffer ofCH 3 COOH, KH 2 PO 4 and H 3 BO 3 at a glucose level of 100 mM. The reaction time was 20 minutes. The peroxidase reaction was run separately after the incubation of the glucose oxidase. It appears from Fig. 1 that the enzyme possesses glucose oxidase activity from approximately pH 4 to above pH 9, having optimum in the range pH 6-7, and more than 75% of maximum activity at pH 8.
  • amino acid sequence of an enzyme may be determined using standard methods for obtaining and sequencing peptides, for example as described by Findlay & Geisow (Eds.), Protein Sequencing - a Practical Approach, 1989, IRL Press.
  • a peptide is considered to be X% homologous to the parent glucose oxidase if a comparison of the respective amino acid sequences, performed via known algorithms, such as the one described by Lipman and Pearson in Science 227, 1985, p. 1435, reveals an identity of X%.
  • the present invention relates to a glucose oxidase comprising an N-terminal amino acid sequence identical to that shown in SEQ ID No. 1 or a glucose oxidase being at least 70% homologous with SEQ ID No .1 in the N-terminal, preferably being at least 80% homologous with SEQ ID No .1 in the N-terminal, more preferably being at least 90% homologous with SEQ ID No. 1.
  • Immunochemical Properties comprising an N-terminal amino acid sequence identical to that shown in SEQ ID No. 1 or a glucose oxidase being at least 70% homologous with SEQ ID No .1 in the N-terminal, preferably being at least 80% homologous with SEQ ID No .1 in the N-terminal, more preferably being at least 90% homologous with SEQ ID No. 1.
  • the immunochemical properties can be determined immunologically by cross-reaction identity tests.
  • the identity tests can be performed by the well-known Ouchterlony double immunodiffusion procedure or by tandem crossed immunoelectrophoresis according to I. M. Roitt; Immunology, Gower Medical Publishing (1985) and N. H. Axelsen; Handbook of Immunoprecipitation-in-Gel Techniques; Blackwell Scientific Publications (1983), Chapters 5 and 14.
  • the terms "antigenic identity” and "partial antigenic identity” are described in the same book, Chapters 5, 19 and 20.
  • Monospecific antiserum may be generated according to the above mentioned method by immunizing rabbits with a glucose oxidase of the invention.
  • the immunogen is mixed with Freund's adjuvant and injected subcutaneously into rabbits every second week.
  • Antiserum is obtained after a total immunization period of 8 weeks, and immunoglobulin prepared therefrom as described by N. H. Axelsen, supra.
  • a glucose oxidase displaying immunochemical cross-reactivity with an antibody raised against a glucose oxidase obtainable from a strain of the genus Cladosporium is preferred, in particular a glucose oxidase having immunochemical properties identical to those of a glucose oxidase obtainable from a strain of the genus Cladosporium.
  • the glucose oxidase of the invention possesses valuable properties allowing for various industrial applications.
  • the enzyme in having activity in the alkaline region, finds potential application in washing detergent compositions as a hydrogen peroxide source, used alone or preferably together with a peroxidase, more preferably used together with a peroxidase and an oxidizable substrate such as an organic compound, such as a phenolic compound, e.g., p-hydroxybenzenesulfonate, or one of the compounds disclosed in WO 94/12621.
  • the enzyme may also be very useful in the baking industry due to its excellent ability for improving the properties of doughs/breads (for documentation see Example 2 + 3).
  • the enzyme also has many potential applications in the personal care area, for example in personal care products such as tooth paste, mouthwash, denture cleaner, liquid soap, skin care creams and lotions, hair care and body care formulations, and solutions for cleaning contact lenses.
  • personal care products such as tooth paste, mouthwash, denture cleaner, liquid soap, skin care creams and lotions, hair care and body care formulations, and solutions for cleaning contact lenses.
  • glucose oxidase of the invention may be very useful in tooth paste, alone or together with other enzymes, preferably together with an amyloglucosidase and a lactoperoxidase as such a combination of enzymes forms a very efficient antibacterial system:
  • the formed hydrogen peroxide may react with thiocyanate in the following way:
  • OSCN- in which OSCN- is a bacteriostatic agent.
  • dough stability is one of the most important characteristics of a baking dough. Stable dough is important for both large scale and small scale applications. A strong dough will exhibit a greater tolerance of mixing time, of proofing time and of mechanical vibrations during dough transport, so that the baked product maintains its good quality. A weak dough will possess less tolerance. Therefore, a strong dough is generally preferred in most breadmaking. A high gluten content and a good gluten quality form a stronger dough than a dough made from a low protein content or with poor gluten quality. In other words, a strong gluten network results in a strong dough, which has superior rheological and handling properties.
  • Dough "conditioners" to strengthen the gluten have long been used.
  • the non-specific oxidants such as bromate, ascorbic acid and peroxides have the gluten strengthening effect. It has been suggested that these conditioners induce the interprotein bonds which strengthen the gluten, thereby the dough.
  • Enzymes used as dough conditioners are also known, e.g. glucose oxidase from Aspergillus niger.
  • the strengthening effect of a given dough conditioner on wheat flour dough or gluten dough may be measured by dynamic rheological measurements. These measurements are able to show the strength of a dough, under oscillation. Both wheat fluor dough and gluten dough are viscoelastic materials. In oscillatory measurements, the viscoelastic properties of a wheat dough and a gluten dough can be divided into two components, the dynamic shear storage modulus G' and the dynamic shear loss modulus G". The ratio of the loss and the storage moduli is numerically equal to the tangent of the viscoelastic phase angle ⁇ . An increase in the storage modulus G' and a decrease in the phase angle ⁇ indicate a stronger and more elastic dough.
  • the bread-improving composition or additive may comprise a glucose oxidase as the only enzyme added, the properties of dough and/or baked products may be further improved when the glucose oxidase is used in combination with one or more additional enzymes.
  • the additional enzyme (s) may either be one or more enzymes present in the glucose oxidase preparation recovered from the organism producing it, or may, more preferably, be added to the bread-improving composition or additive.
  • the additional enzyme is selected from the group consisting of an amylase, in particular an amyloglucosidase, an ⁇ -amylase or a maltogenic exo-amylase (at present contemplated useful for providing sugars fermentable by yeast), a peptidase, a maltogenase, a lipase, a cellulase, a hemicellulase, in particular a xylanase, a protease (at present contemplated useful for gluten weakening in particular when using hard wheat flour), and an oxidoreductase, e.g., a peroxidase, a laccase, a protein disulfide isomerase, e.g., a protein disulfide isomerase as disclosed in WO 95/00636, or an additional glucose oxidase.
  • an amylase in particular an amyloglucosidase, an ⁇ -amylase or a maltogenic
  • the additional enzyme is selected from the group consisting of a hemicellulase, in particular a xylanase, and an amylase, e.g., an amyloglucosidase, an ⁇ -amylase or a maltogenic exo-amylase.
  • the additional enzyme is preferably of microbial (bacterial, yeast or fungal) origin and may be obtained by techniques conventionally used in the art.
  • the amylase may be derived from a bacterium or a fungus, in particular from a strain of Aspergillus, preferably a strain of Aspergillus niger or Aspergillus oryzae, or from a strain of Bacillus.
  • ⁇ -amylases useful for the present purpose are FungamylTM (an Aspergillus oryzae ⁇ -amylase, available from Novo Nordisk A/S, Denmark), NovamylTM (a Bacillus stearothermophilus maltogenic exo-amylase, available from Novo Nordisk A/S, Denmark), and BANTM (a Bacillus amyloliquefaciens ⁇ -amylase, available from Novo Nordisk A/S, Denmark).
  • the amyloglucosidase may in particular be AMGTM (an A. niger amyloglucosidase, available from Novo Nordisk A/S, Denmark).
  • Other useful amylase products include GrindamylTM A 1000 or A 5000 (available from Grindsted Products, Denmark) and AmylaseTM H or AmylaseTM P (available from Gist-Brocades, The Netherlands).
  • the additional glucose oxidase may be a fungal glucose oxidase, in particular GluzymeTM (an Aspergillus niger glucose oxidase, available from Novo Nordisk A/S, Denmark).
  • GluzymeTM an Aspergillus niger glucose oxidase, available from Novo Nordisk A/S, Denmark.
  • the protease may in particular be NeutraseTM (available from Novo Nordisk A/S, Denmark).
  • the lipase may be derived from a strain of Thermomyces, a strain of Rhizomucor, a strain of Candida, a strain of Aspergillus, a strain of Rhizopus, or a strain of Pseudomonas.
  • the lipase may be derived from a strain of Thermomyces lanuginosus, a strain of Rhizomucor miehei, a strain of Candida antarctica, a strain of Aspergillus niger, or a strain of Pseudomonas cepacia.
  • the lipase may be Lipase A or Lipase B derived from a strain of Candida antarctica as described in WO 88/02775, or the lipase may be derived from a strain of Rhizomucor miehei as described in EP 238,023, or a strain of Humicola lanuginosa described in EP 305,216, or a strain of Pseudomonas cepacia as described in EP 214,761 and WO 89/01032.
  • a microbial produced glucose oxidase preparation may contain varying minor amounts of other enzymatic activities inherently produced by the producer organism in question.
  • the glucose oxidase may typically be a component (a hydrogen peroxide source) of a detergent composition, e.g., a laundry detergent composition or a dishwashing detergent composition.
  • a detergent composition e.g., a laundry detergent composition or a dishwashing detergent composition.
  • it may be included in the detergent composition in the form of a non-dusting granulate, a stabilized liquid, or a protected enzyme.
  • Non-dusting granulates may be produced, e.g., as disclosed in US 4,106,991 and 4,661,452 (both to Novo Industri A/S) and may optionally be coated by methods known in the art. Examples of waxy coating materials are poly (ethylene oxide) products
  • polyethyleneglycol, PEG polyethyleneglycol, PEG with mean molecular weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids.
  • film-forming coating materials suitable for application by fluid bed techniques are given in patent GB 1483591.
  • Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods. Other enzyme stabilizers are well known in the art.
  • Protected enzymes may be prepared according to the method disclosed in EP 238,216.
  • the detergent composition of the invention may be in any convenient form, e.g. as powder, granules, paste or liquid.
  • a liquid detergent may be aqueous, typically containing up to 70% water and 0-30% organic solvent, or nonaqueous.
  • the detergent composition comprises one or more surfactants, each of which may be anionic, nonionic, cationic, or amphoteric (zwitterionic).
  • the detergent will usually contain 0-50% of anionic surfactant such as linear alkylbenzene-sulfonate (LAS), alpha-olefinsulfonate (AOS), alkyl sulfate
  • fatty alcohol sulfate AS
  • AEOS alcohol ethoxysulfate
  • AES secondary alkanesulfonates
  • SAS secondary alkanesulfonates
  • alpha-sulfo fatty acid methyl esters alkyl- or alkenylsuccinic acid, or soap.
  • It may also contain 0-40% of nonionic surfactant such as alcohol ethoxylate (AEO or AE), alcohol propoxylate, carboxylated alcohol ethoxylates, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamine oxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, or polyhydroxy alkyl fatty acid amide (e.g. as described in WO 92/06154).
  • AEO or AE alcohol ethoxylate
  • alcohol propoxylate carboxylated alcohol ethoxylates
  • nonylphenol ethoxylate nonylphenol ethoxylate
  • alkylpolyglycoside alkyldimethylamine oxide
  • the detergent composition may additionally comprise one or more other enzymes, such as pullulanase, esterase, lipase, cutinase, protease, cellulase, or peroxidase.
  • enzymes such as pullulanase, esterase, lipase, cutinase, protease, cellulase, or peroxidase.
  • the detergent contains 1-65% of a detergent builder, but some dishwashing detergents may contain even up to 90% of a detergent builder, or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, citrate, nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid
  • EDTA diethylenetriaminepentaacetic acid
  • DTMPA diethylenetriaminepentaacetic acid
  • alkyl- or alkenylsuccinic acid soluble silicates or layered silicates
  • the detergent builders may be subdivided into phosphorus-containing and non-phosphorous-containing types.
  • Examples of phosphorus-containing inorganic alkaline detergent builders include the water-soluble salts, especially alkali metal pyrophosphates, orthophosphates, polyphosphates and phosphonates.
  • Examples of non-phosphorus-containing inorganic builders include water-soluble alkali metal carbonates, borates and silicates as well as layered disilicates and the various types of water-insoluble crystalline or amorphous alumino silicates of which zeolites is the best known representative.
  • suitable organic builders include alkali metal, ammonium or substituted ammonium salts of succinates, malonates, fatty acid malonates, fatty acid sulphonates, carboxymethoxy succinates, polyacetates, carboxylates, polycarboxylates, aminopolycarboxylates and polyacetyl carboxylates.
  • the detergent may also be unbuilt, i.e. essentially free of detergent builder.
  • the detergent may comprise one or more polymers.
  • examples are carboxymethylcellulose (CMC), poly(vinylpyrrolidone) (PVP), polyethyleneglycol (PEG), poly(vinyl alcohol) (PVA), polycarboxylates such as polyacrylates, polymaleates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • CMC carboxymethylcellulose
  • PVP poly(vinylpyrrolidone)
  • PEG polyethyleneglycol
  • PVA poly(vinyl alcohol)
  • polycarboxylates such as polyacrylates, polymaleates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
  • the detergent composition may additionally contain other bleaching agents of the chlorine/bromine-type or the oxygen-type.
  • the bleaching agents may be coated or encapsulated.
  • inorganic chlorine/bromine-type bleaches are lithium, sodium or calcium hypochlorite or hypobromite as well as chlorinated trisodium phosphate.
  • organic chlorine/bromine-type bleaches are heterocyclic N-bromo and N-chloro imides such as trichloroisocyanuric, tribromoisocyanuric, dibromoisocyanuric and dichloroisocyanuric acids, and salts thereof with water solubilizing cations such as potassium and sodium.
  • Hydantoin compounds are also suitable.
  • the bleaching system may also comprise peroxyacids of, e.g., the amide, imide, or sulfone type.
  • oxygen bleaches are preferred, for example in the form of an inorganic persalt, preferably with a bleach precursor or as a peroxy acid compound.
  • suitable peroxy bleach compounds are alkali metal perborates, both tetrahydrates and monohydrates, alkali metal percarbonates, persilicates and perphosphates.
  • Preferred activator materials are TAED or NOBS.
  • the enzymes of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g. a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative such as, e.g., an aromatic borate ester, and the composition may be formulated as described in, e.g., WO 92/19709 and WO 92/19708.
  • the enzymes of the invention may also be stabilized by adding reversible enzyme inhibitors, e.g., of the protein type as described in EP 0 544 777 B1.
  • the detergent may also contain other conventional detergent ingredients such as, e.g., fabric conditioners including clays, deflocculant material, foam boosters/foam depressors (in dishwashing detergents foam depressors), suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil-redeposition agents, dyes, dehydrating agents, bactericides, optical brighteners, or perfume.
  • fabric conditioners including clays, deflocculant material, foam boosters/foam depressors (in dishwashing detergents foam depressors), suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil-redeposition agents, dyes, dehydrating agents, bactericides, optical brighteners, or perfume.
  • the pH (measured in aqueous solution at use concentration) will usually be neutral or alkaline, e.g. in the range of 7-11.
  • laundry detergent compositions within the scope of the invention include:
  • a detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
  • a detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
  • a detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
  • a detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
  • An aqueous liquid detergent composition comprising
  • An aqueous structured liquid detergent composition comprising
  • a detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
  • a detergent composition formulated as a granulate comprising
  • a detergent composition formulated as a granulate comprising
  • An aqueous liquid detergent composition comprising 11) An aqueous liquid detergent composition comprising
  • a detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
  • a detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
  • a detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
  • the manganese catalyst may, e.g., be one of the compounds described in "Efficient manganese catalysts for low-temperature bleaching", Nature 369, 1994, pp. 637-639.
  • Detergent composition formulated as a nonaqueous detergent liquid comprising a liquid nonionic surfactant such as, e.g., linear alkoxylated primary alcohol, a builder system (e.g. phosphate), enzyme and alkali.
  • a liquid nonionic surfactant such as, e.g., linear alkoxylated primary alcohol, a builder system (e.g. phosphate), enzyme and alkali.
  • the detergent may also comprise anionic surfactant and/or a bleach system.
  • dishwashing detergent compositions within the scope of the invention include: 1) POWDER AUTOMATIC DISHWASHING COMPOSITION
  • the manganese catalyst may, e.g., be one of the compounds described in "Efficient manganese catalysts for low-temperature bleaching", Nature 369, 1994, pp. 637-639.
  • the glucose oxidase of the invention may be incorporated in concentrations conventionally employed in detergents. It is at present contemplated that, in the detergent composition of the invention, the glucose oxidase may be added in an amount corresponding to 0.00001-1 mg (calculated as pure enzyme protein) of glucose oxidase per liter of wash/dishwash liquor.
  • the present invention is further illustrated in the following examples which are not intended to be in any way limiting to the scope of the invention as claimed.
  • the glucose oxidase of the invention may be produced by the method described in this example.
  • the glucose oxidase producing strain e.g., Cladosporium oxysporum, CBS 163.94, was inoculated on agar plates containing a medium of the following composition:
  • the agar was cut into pieces and transferred aseptically to shake flasks, each flask containing 100 ml of inoculation medium of the following composition:
  • the flasks were incubated on a rotary shaker at 250 rpm, at 26°C, for 24 hours. The contents of these flasks were used for the inoculation of the production flasks which contained the following production medium (100 ml per flask): NaNO 3 3 g/l
  • glucose oxidase was filtrated and concentrated using a FiltronTM ultrafiltration module with a 10 kDa cut off membrane and filtrated again.
  • the enzyme solution was then purified by hydrophobic interaction using the following conditions:
  • glucose oxidase solution was ultrafiltrated again, this time using a 20 kDa cut off membrane. Finally a ionexchange chromatography purification took place using a Pharmacia LKB HPLC/25°C system using piperazine as buffer.
  • the MW and the pi of the glucose oxidase were estimated to 90-100 kDa (SDS-PAGE) and 4.1-4.3 (IEF) respectively.
  • the found molecular weight (MW) may be that of a subunit (monomer).
  • pH Profile The pH profile was performed using a glucose oxidase preparation which after fermentation as described above was ultrafiltrated using a 10 kDa cut off membrane and then precipitated with ethanol 55% (w/w) whereafter it was ultrafiltrated again resulting in a preparation with an activity of 200 UNITS/ml. The preparation was used to determine the pH profile previously described in this specification.
  • the dynamic shear storage modulus G' and the viscoelastic phase angle ⁇ were measured in the gluten from 4 doughs, which were treated with different conditioners.
  • the conditioners were added to the flour before dough mixing.
  • the gluten was washed out of the flour dough containing the conditioner after the flour dough had been incubated at 32°C for 1M hours.
  • the results of the tests are presented in Figs. 2 and 3. The following symbols were used:
  • a dough containing 20 ppm KBrO 3 .
  • KBrO 3 is a traditional dough conditioner;
  • a dough containing 500 UNITS per kg of flour of a glucose oxidase from A. niger;
  • the storage modulus G' of the gluten treated with the glucose oxidase of the invention is significantly higher than the G' of the gluten treated with the traditional glucose oxidase, dosed with the same amount of units, and also higher than the G' of the traditional dough conditioner KBrO 3 .
  • This result suggests that the gluten, thereby the dough, is significantly strengthened by addition of the glucose oxidase of the invention.
  • Fig. 3 shows that the traditional dough conditioner KBrO 3 as expected lowers the phase angle ⁇ compared to the reference with no added conditioner; this indicates a more elastic rheological property. This decrease in phase angle is also found with the traditional glucose oxidase from A. niger. However, when using the glucose oxidase of the invention the phase angle ⁇ is decreased even more when compared with the traditional conditioners.
  • the mixing time was determined and adjusted by a skilled baker so as to obtain an optimum dough consistence under the testing conditions used.
  • Loaf specific volume The mean value of 4 loaves volume were measured using the traditional rape seed method. The specific volume was calculated as volume ml per g bread. The specific volume of the control (without enzyme) was defined as 100. The relative specific volume index was calculated as:
  • glucose oxidase of the invention has a significant effect on improving the baking quality of flour.
  • the specific volume increased between 10% to 20%, and the breads also performed very well after shock test.
  • the colour, the crust crispy and the crumb structure were also improved after adding glucose oxidase, only the crumb structure did not perform so satisfactory if the glucose oxidase is dosed higher than 400-500 UNITS per kg flour.

Abstract

A glucose oxidase characterized by a pH-optimum in the range pH 6-7, having more than 75 % of maximum activity at pH 8, determined at 30 °C with D-glucose as substrate.

Description

ALKALINE GLUCOSE OXIDASE
FIELD OF INVENTION
The present invention relates to a novel glucose oxidase, to a process for its production and to its use in bleaching and detergent compositions, as well as to its use as a dough strengthener.
BACKGROUND OF THE INVENTION
Glucose oxidases are enzymes that catalyze the oxidation of glucose with oxygen whereby hydrogen peroxide is formed. Such enzymes are known from microbial, plant and animal origins, e.g., glucose oxidase from Aspergillus, Penicillium and Talaromyces. Glucose oxidase has been described as useful for various purposes, e.g., for bleaching purposes and in the baking industry, useful for strengthening the dough.
An example of a commercial glucose oxidase is
Gluzyme™, an Aspergillus niger glucose oxidase, available from Novo Nordisk A/S. This and similar products from other commercial sources have an acidic pH optimum, typically around pH 5, which means that they are not very active in detergent solu¬tions due to the alkaline character of the detergents.
It is an object of the present invention to provide novel glucose oxidases with improved performance in neutral and alkaline solutions.
SUMMARY OF THE INVENTION In this invention it is surprisingly found that a glucose oxidase with a neutral pH optimum may be produced from strains of Cladosporium.
Accordingly, the present invention relates to a glucose oxidase characterized by a pH-optimum in the range pH 6-7, having more than 75% of maximum activity at pH 8, deter mined at 30°C with D-glucose as substrate. BRIEF DESCRIPTION OF DRAWINGS
The present invention is further illustrated by reference to the accompanying drawings, in which
Fig. 1 shows the relation between pH and the glucose oxidase activity of a novel glucose oxidase according to the invention (the glucose oxidase obtained according to Example 1), with D-glucose as substrate in the presence of oxygen at 30°C, using a buffer system adjusted to predetermined pH values of from pH 4 to pH 9.
Fig. 2 shows the dynamic shear storage modulus G' in gluten from 4 different doughs characterized with the following symbols:
□: a dough with no added conditioner (= reference)
∇ : a dough containing 20 ppm KBrO3.
♢: a dough containing 500 UNITS per kg of flour of a glucose oxidase from A. niger.
Δ: a dough containing 500 UNITS per kg of flour of a glucose oxidase of the invention, obtained as described in Example 1.
Fig. 3 shows the viscoelastic phase angle δ in gluten from 4 different doughs characterized with the following symbols:
□: a dough with no added conditioner (= reference)
∇ a dough containing 20 ppm KBrO3.
♢ a dough containing 500 UNITS per kg of flour of a glucose oxidase from A. niger.
Δ: a dough containing 500 UNITS per kg of flour of a glucose oxidase of the invention, obtained as described in Example 1.
DETAILED DESCRIPTION OF THE INVENTION Microorganism
According to the invention, glucose oxidase is obtainable from a glucose oxidase producing strain of Clado sporium, preferably Cladosporium oxysporum.
The genus Cladosporium is characterized primarily by the formation of conidia in branching chains, which are very fragile and readily break up into units. The conidia can be either hyaline or pigmented, smooth or roughened, continuous or septate. The conidiophores are erect and pigmented, branching irregularly at the apex. Cladosporium oxysporum is further described by M. B. Ellis in Dermatiaceous Hyphomycetes, 1971, p. 312, CAB International, UK.
A strain representative of Cladosporium oxysporum has been deposited according to the Budapest Treaty on the International Recognition of the Deposits of Microorganisms for the Purpose of Patent Procedures, on 25 March 1994, at Centraal-bureau voor Schimmelcultures (CBS), under Accession No. CBS 163.94.
Production of Glucose Oxidase
Glucose oxidase of the invention may be produced by aerobic cultivation of the above mentioned microbial strain on a nutrient medium containing suitable carbon and nitrogen sources, such media being known in the art. A temperature in the range of from 20°C to 30°C is suitable for growth and glucose oxidase production.
Alternatively, glucose oxidase of the invention can be produced by aerobic cultivation of a transformed host organism containing the appropriate genetic information from the above mentioned strain. Such transformants can be prepared and cultivated by methods known in the art:
Cloning a DNA Sequence Encoding a Glucose Oxidase
The DNA sequence encoding a glucose oxidase of the invention may be isolated from any cell or microorganism producing the glucose oxidase in question, using various methods well known in the art. First, a genomic DNA and/or cDNA library should be constructed using chromosomal DNA or messenger RNA from the organism that produces the glucose oxidase to be studied. Then, if the amino acid sequence of the glucose oxidase is known, homologous, labelled oligonucleotide probes may be synthesized and used to identify glucose oxidase- encoding clones from a genomic library prepared from the organism in question. Alternatively, a labelled oligonucleotide probe containing sequences homologous to a known glucose oxidase gene could be used as a probe to identify glucose oxidase-encoding clones, using hybridization and washing conditions of lower stringency. According to the present invention preferred probes may be constructed on the basis of SEQ ID No. 1.
Yet another method for identifying glucose oxidase-encoding clones would involve inserting fragments of genomic DNA into an expression vector, such as a plasmid, transforming glucose oxidase-negative bacteria with the resulting genomic DNA library, and then plating the transformed bacteria onto agar containing a substrate for glucose oxidase thereby allowing clones expressing the glucose oxidase to be identified.
Alternatively, the DNA sequence encoding the enzyme may be prepared synthetically by established standard methods, e.g. the phosphoamidite method described by S.L. Beaucage and M.H. Caruthers in Tetrahedron Letters 22, 1981, pp. 1859-1869 or the method described by Matthes et al. in The EMBO J. 3, 1984, pp. 801-805. In the phosphoamidite method, oligonucleotides are synthesized, e.g. in an automatic DNA synthesizer, purified, annealed, ligated and cloned in appropriate vectors.
Finally, the DNA sequence may be of mixed genomic and synthetic origin, mixed synthetic and cDNA origin or mixed genomic and cDNA origin, prepared by ligating fragments of synthetic, genomic or cDNA origin (as appropriate, the fragments corresponding to various parts of the entire DNA sequence), in accordance with standard techniques. The DNA sequence may also be prepared by polymerase chain reaction (PCR) using specific primers, for instance as described in US 4,683,202 or R.K. Saiki et al. in Science 239, 1988, pp. 487- 491 ,
Expression of Glucose Oxidase
According to the invention, a glucose oxidase-encoding DNA sequence produced by methods described above, or by any alternative methods known in the art, can be expressed, in enzyme form, using an expression vector which typically includes control sequences encoding a promoter, operator, ribosome binding site, translation initiation signal, and, optionally, a repressor gene or various activator genes.
The recombinant expression vector carrying the DNA sequence encoding a glucose oxidase of the invention may be any vector which may conveniently be subjected to recombinant DNA procedures, and the choice of vector will often depend on the host cell into which it is to be introduced. Thus, the vector may be an autonomously replicating vector, i.e. a vector which exists as an extrachromosomal entity, the replication of which is independent of chromosomal replication, e.g., a plasmid, a bacteriophage or an extrachromosomal element, minichromosome or an artificial chromosome. Alternatively, the vector may be one which, when introduced into a host cell, is integrated into the host cell genome and replicated together with the chromosome (s) into which it has been integrated.
In the vector, the DNA sequence should be operably connected to a suitable promoter sequence. The promoter may be any DNA sequence which shows transcriptional activity in the host cell of choice and may be derived from genes encoding proteins either homologous or heterologous to the host cell. Examples of suitable promoters for directing the transcription of the DNA sequence encoding a glucose oxidase of the inven¬tion, especially in a bacterial host, are the promoter of the lac operon of E.coli, the Streptomyces coelicolor agarase gene dagA promoters, the promoters of the Bacillus licheniformis α-amylase gene (amyL), the promoters of the Bacillus stearothermophilus maltogenic amylase gene (amyM), the promoters of the Bacillus Amyloliquefaciens α-amylase (amyO), the promoters of the Bacillus subtilis xylA and xylB genes etc. For transcription in a fungal host, examples of useful promoters are those derived from the gene encoding A. oryzae TAKA amylase, Rhizomucor miehei aspartic proteinase, A. niger neutral α-amylase, A. niger acid stable α-amylase, A. niger glucoamylase, Rhizomucor miehei lipase, A. oryzae alkaline protease, A. oryzae triose phosphate isomerase or A. nidulans acetamidase.
The expression vector of the invention may also comprise a suitable transcription terminator and, in eukaryotes, polyadenylation sequences operably connected to the DNA sequence encoding the glucose oxidase of the invention. Termination and polyadenylation sequences may suitably be derived from the same sources as the promoter.
The vector may further comprise a DNA sequence enabling the vector to replicate in the host cell in question. Examples of such sequences are the origins of replication of plasmids pUC19, pACYC177, pUB110, pE194, pAMB1 and pIJ702.
The vector may also comprise a selectable marker, e.g., a gene the product of which complements a defect in the host cell, such as the dal genes from B. subtilis or B. licheniformis, or one which confers antibiotic resistance such as ampicillin, kanamycin, chloramphenicol or tetracyclin resistance. Furthermore, the vector may comprise Aspergillus selection markers such as amdS, argB, niaD and sC, a marker giving rise to hygromycin resistance, or the selection may be accomplished by co-transformation, e.g., as described in WO 91/17243.
While intracellular expression may be advantageous in some respects, e.g., when using certain bacteria as host cells, it is generally preferred that the expression is extracellular.
Procedures suitable for constructing vectors of the invention encoding a glucose oxidase and containing the promoter, terminator and other elements, respectively, are well known to persons skilled in the art (cf., for instance, Sambrook et al. in Molecular Cloning: A Laboratory Manual, 2nd Ed., Cold Spring Harbor, 1989).
The cell of the invention, either comprising a DNA construct or an expression vector of the invention as defined above, is advantageously used as a host cell in the recombinant production of a glucose oxidase of the invention. The cell may be transformed with the DNA construct of the invention encoding the glucose oxidase conveniently by integrating the DNA construct (in one or more copies) in the host chromosome. This integration is generally considered to be an advantage as the DNA sequence is more likely to be stably maintained in the cell. Integration of the DNA constructs into the host chromosome may be performed according to conventional methods, e.g., by homologous or heterologous recombination. Alternatively, the cell may be transformed with an expression vector as described above in connection with the different types of host cells.
The cell of the invention may be a cell of a higher organism such as a mammal or an insect, but is preferably a microbial cell, e.g., a bacterial or a fungal (including yeast) cell.
Examples of suitable bacteria are grampositive bacteria such as Bacillus subtilis, Bacillus licheniformis, Bacillus lentus, Bacillus brevis, Bacillus stearothermophilus, Bacillus alkalophilus, Bacillus amyloliquefaciens, Bacillus coagulans, Bacillus circulans, Bacillus lautus, Bacillusmegaterium, Bacillus thuringiensis, or Streptomyces lividans or
Streptomyces murinus, or gramnegative bacteria such as E.coli.
The transformation of the bacteria may, for instance, be effected by protoplast transformation or by using competent cells in a manner known per se.
The yeast organism may favourably be selected from a species of Saccharomyces or Schizosaccharomyces, e.g., Saccharomyces cerevisiae. The filamentous fungus may advantageously belong to a species of Aspergillus, e.g., Aspergillus oryzae or Aspergillus niger. Fungal cells may be transformed bya process involving protoplast formation and transformation of the protoplasts followed by regeneration of the cell wall in a manner known per se. A suitable procedure for transformation of Aspergillus host cells is described in EP 238 023.
In a yet further aspect, the present invention relates to a method of producing a glucose oxidase of the invention, which method comprises cultivating a host cell as described above under conditions conducive to the production of the glucose oxidase and recovering the glucose oxidase from the cells and/or culture medium.
The medium used to cultivate the cells may be any conventional medium suitable for growing the host cell in question and obtaining expression of the glucose oxidase of the invention. Suitable media are available from commercial suppliers or may be prepared according to published recipes (e.g., as described in catalogues of the American Type Culture Collection).
The glucose oxidase secreted from the host cells may conveniently be recovered from the culture medium by well-known procedures, including separating the cells from the medium by centrifugation or filtration, and precipitating proteinaceous components of the medium by means of a salt such as ammonium sulphate, followed by the use of chromatographic procedures such as ion exchange chromatography, affinity chromatography, or the like.
Assay for Glucose Oxidase Activity
Glucose oxidase activity is determined in the following way: Glucose oxidase oxidizes D-glucose in the presence of oxygen producing hydrogen peroxide. The hydrogen peroxide formed, in the presence of peroxidase, oxidizes ABTS
(2,2'-azinobis(3-ethylbenzothiazoline-6-sulfonate)). The greenish-blue colour resulting after a fixed reaction time measured as the absorbance at 418 nm is a function of the amount of hydrogen peroxide. In the assay the following concentrations, pH, temperature and reaction time are used: D-glucose: 100 mM; ABTS: 0.4 mM; phosphate buffer: 100 mM; pH:7.0; temperature: 30°C; reaction time: 20 min. The activity of glucose oxidase is given in UNITS (1 UNIT is the amount of glucose oxidase which under the above standard conditions forms 1 μmole of hydrogen peroxide per minute).
Physico-chemical Properties of the Glucose Oxidase
The glucose oxidase of the invention (obtained according to Example 1) possesses the following property:
A pH profile as shown in Fig. 1, which was determined at 30°C in the pH range of from pH 4 to pH 9. The assay for glucose oxidase activity described above was run in a buffer ofCH3COOH, KH2PO4 and H3BO3 at a glucose level of 100 mM. The reaction time was 20 minutes. The peroxidase reaction was run separately after the incubation of the glucose oxidase. It appears from Fig. 1 that the enzyme possesses glucose oxidase activity from approximately pH 4 to above pH 9, having optimum in the range pH 6-7, and more than 75% of maximum activity at pH 8.
N-terminal.
An amino acid sequence of an enzyme may be determined using standard methods for obtaining and sequencing peptides, for example as described by Findlay & Geisow (Eds.), Protein Sequencing - a Practical Approach, 1989, IRL Press.
The N-terminal amino acid sequence of the glucose oxidase obtained from Cladosporium oxysporum, CBS 163.94, fermented and purified as described in Example 1, was found to be :
Ala-Ser-Pro-Ala-Glu-Pro-Pro-Val-Val-Ala-Ala (SEQ ID No. 1).
A peptide is considered to be X% homologous to the parent glucose oxidase if a comparison of the respective amino acid sequences, performed via known algorithms, such as the one described by Lipman and Pearson in Science 227, 1985, p. 1435, reveals an identity of X%.
The present invention relates to a glucose oxidase comprising an N-terminal amino acid sequence identical to that shown in SEQ ID No. 1 or a glucose oxidase being at least 70% homologous with SEQ ID No .1 in the N-terminal, preferably being at least 80% homologous with SEQ ID No .1 in the N-terminal, more preferably being at least 90% homologous with SEQ ID No. 1. Immunochemical Properties
The immunochemical properties can be determined immunologically by cross-reaction identity tests. The identity tests can be performed by the well-known Ouchterlony double immunodiffusion procedure or by tandem crossed immunoelectrophoresis according to I. M. Roitt; Immunology, Gower Medical Publishing (1985) and N. H. Axelsen; Handbook of Immunoprecipitation-in-Gel Techniques; Blackwell Scientific Publications (1983), Chapters 5 and 14. The terms "antigenic identity" and "partial antigenic identity" are described in the same book, Chapters 5, 19 and 20.
Monospecific antiserum may be generated according to the above mentioned method by immunizing rabbits with a glucose oxidase of the invention. The immunogen is mixed with Freund's adjuvant and injected subcutaneously into rabbits every second week. Antiserum is obtained after a total immunization period of 8 weeks, and immunoglobulin prepared therefrom as described by N. H. Axelsen, supra.
According to the invention a glucose oxidase displaying immunochemical cross-reactivity with an antibody raised against a glucose oxidase obtainable from a strain of the genus Cladosporium is preferred, in particular a glucose oxidase having immunochemical properties identical to those of a glucose oxidase obtainable from a strain of the genus Cladosporium. Industrial Applications
The glucose oxidase of the invention possesses valuable properties allowing for various industrial applications. In particular the enzyme, in having activity in the alkaline region, finds potential application in washing detergent compositions as a hydrogen peroxide source, used alone or preferably together with a peroxidase, more preferably used together with a peroxidase and an oxidizable substrate such as an organic compound, such as a phenolic compound, e.g., p-hydroxybenzenesulfonate, or one of the compounds disclosed in WO 94/12621.
The enzyme may also be very useful in the baking industry due to its excellent ability for improving the properties of doughs/breads (for documentation see Example 2 + 3).
The enzyme also has many potential applications in the personal care area, for example in personal care products such as tooth paste, mouthwash, denture cleaner, liquid soap, skin care creams and lotions, hair care and body care formulations, and solutions for cleaning contact lenses. In particular the glucose oxidase of the invention may be very useful in tooth paste, alone or together with other enzymes, preferably together with an amyloglucosidase and a lactoperoxidase as such a combination of enzymes forms a very efficient antibacterial system:
Polysaccharides from plaques - -> (Amyloglucosidase)
Glucose - -> (Glucose oxidase of the invention)
Gluconic acid + H2O2 ;
the formed hydrogen peroxide may react with thiocyanate in the following way:
H2O2 + SCN- - -> (Lactoperoxidase)
OSCN-, in which OSCN- is a bacteriostatic agent.
Gluten Strengthening
It is generally known that dough stability is one of the most important characteristics of a baking dough. Stable dough is important for both large scale and small scale applications. A strong dough will exhibit a greater tolerance of mixing time, of proofing time and of mechanical vibrations during dough transport, so that the baked product maintains its good quality. A weak dough will possess less tolerance. Therefore, a strong dough is generally preferred in most breadmaking. A high gluten content and a good gluten quality form a stronger dough than a dough made from a low protein content or with poor gluten quality. In other words, a strong gluten network results in a strong dough, which has superior rheological and handling properties.
Dough "conditioners" to strengthen the gluten have long been used. The non-specific oxidants, such as bromate, ascorbic acid and peroxides have the gluten strengthening effect. It has been suggested that these conditioners induce the interprotein bonds which strengthen the gluten, thereby the dough. Enzymes used as dough conditioners are also known, e.g. glucose oxidase from Aspergillus niger.
The strengthening effect of a given dough conditioner on wheat flour dough or gluten dough may be measured by dynamic rheological measurements. These measurements are able to show the strength of a dough, under oscillation. Both wheat fluor dough and gluten dough are viscoelastic materials. In oscillatory measurements, the viscoelastic properties of a wheat dough and a gluten dough can be divided into two components, the dynamic shear storage modulus G' and the dynamic shear loss modulus G". The ratio of the loss and the storage moduli is numerically equal to the tangent of the viscoelastic phase angle δ . An increase in the storage modulus G' and a decrease in the phase angle δ indicate a stronger and more elastic dough.
Baking industry/Additional Enzyme Activities
While the bread-improving composition or additive may comprise a glucose oxidase as the only enzyme added, the properties of dough and/or baked products may be further improved when the glucose oxidase is used in combination with one or more additional enzymes.
The additional enzyme (s) may either be one or more enzymes present in the glucose oxidase preparation recovered from the organism producing it, or may, more preferably, be added to the bread-improving composition or additive.
In a preferred embodiment, the additional enzyme is selected from the group consisting of an amylase, in particular an amyloglucosidase, an α-amylase or a maltogenic exo-amylase (at present contemplated useful for providing sugars fermentable by yeast), a peptidase, a maltogenase, a lipase, a cellulase, a hemicellulase, in particular a xylanase, a protease (at present contemplated useful for gluten weakening in particular when using hard wheat flour), and an oxidoreductase, e.g., a peroxidase, a laccase, a protein disulfide isomerase, e.g., a protein disulfide isomerase as disclosed in WO 95/00636, or an additional glucose oxidase.
In a more preferred embodiment, the additional enzyme is selected from the group consisting of a hemicellulase, in particular a xylanase, and an amylase, e.g., an amyloglucosidase, an α-amylase or a maltogenic exo-amylase.
The additional enzyme is preferably of microbial (bacterial, yeast or fungal) origin and may be obtained by techniques conventionally used in the art.
The amylase may be derived from a bacterium or a fungus, in particular from a strain of Aspergillus, preferably a strain of Aspergillus niger or Aspergillus oryzae, or from a strain of Bacillus. Commercially available α-amylases useful for the present purpose are Fungamyl™ (an Aspergillus oryzae α-amylase, available from Novo Nordisk A/S, Denmark), Novamyl™ (a Bacillus stearothermophilus maltogenic exo-amylase, available from Novo Nordisk A/S, Denmark), and BAN™ (a Bacillus amyloliquefaciens α-amylase, available from Novo Nordisk A/S, Denmark). The amyloglucosidase may in particular be AMG™ (an A. niger amyloglucosidase, available from Novo Nordisk A/S, Denmark). Other useful amylase products include Grindamyl™ A 1000 or A 5000 (available from Grindsted Products, Denmark) and Amylase™ H or Amylase™ P (available from Gist-Brocades, The Netherlands).
The additional glucose oxidase may be a fungal glucose oxidase, in particular Gluzyme™ (an Aspergillus niger glucose oxidase, available from Novo Nordisk A/S, Denmark).
The protease may in particular be Neutrase™ (available from Novo Nordisk A/S, Denmark).
The lipase may be derived from a strain of Thermomyces, a strain of Rhizomucor, a strain of Candida, a strain of Aspergillus, a strain of Rhizopus, or a strain of Pseudomonas. In particular the lipase may be derived from a strain of Thermomyces lanuginosus, a strain of Rhizomucor miehei, a strain of Candida antarctica, a strain of Aspergillus niger, or a strain of Pseudomonas cepacia. In specific embodiments, the lipase may be Lipase A or Lipase B derived from a strain of Candida antarctica as described in WO 88/02775, or the lipase may be derived from a strain of Rhizomucor miehei as described in EP 238,023, or a strain of Humicola lanuginosa described in EP 305,216, or a strain of Pseudomonas cepacia as described in EP 214,761 and WO 89/01032.
Besides the above mentioned additional enzymes, a microbial produced glucose oxidase preparation may contain varying minor amounts of other enzymatic activities inherently produced by the producer organism in question.
Detergent Compositions
According to the invention, the glucose oxidase may typically be a component (a hydrogen peroxide source) of a detergent composition, e.g., a laundry detergent composition or a dishwashing detergent composition. As such, it may be included in the detergent composition in the form of a non-dusting granulate, a stabilized liquid, or a protected enzyme. Non-dusting granulates may be produced, e.g., as disclosed in US 4,106,991 and 4,661,452 (both to Novo Industri A/S) and may optionally be coated by methods known in the art. Examples of waxy coating materials are poly (ethylene oxide) products
(polyethyleneglycol, PEG) with mean molecular weights of 1000 to 20000; ethoxylated nonylphenols having from 16 to 50 ethylene oxide units; ethoxylated fatty alcohols in which the alcohol contains from 12 to 20 carbon atoms and in which there are 15 to 80 ethylene oxide units; fatty alcohols; fatty acids; and mono- and di- and triglycerides of fatty acids. Examples of film-forming coating materials suitable for application by fluid bed techniques are given in patent GB 1483591. Liquid enzyme preparations may, for instance, be stabilized by adding a polyol such as propylene glycol, a sugar or sugar alcohol, lactic acid or boric acid according to established methods. Other enzyme stabilizers are well known in the art. Protected enzymes may be prepared according to the method disclosed in EP 238,216.
The detergent composition of the invention may be in any convenient form, e.g. as powder, granules, paste or liquid. A liquid detergent may be aqueous, typically containing up to 70% water and 0-30% organic solvent, or nonaqueous.
The detergent composition comprises one or more surfactants, each of which may be anionic, nonionic, cationic, or amphoteric (zwitterionic). The detergent will usually contain 0-50% of anionic surfactant such as linear alkylbenzene-sulfonate (LAS), alpha-olefinsulfonate (AOS), alkyl sulfate
(fatty alcohol sulfate) (AS), alcohol ethoxysulfate (AEOS or
AES), secondary alkanesulfonates (SAS), alpha-sulfo fatty acid methyl esters, alkyl- or alkenylsuccinic acid, or soap. It may also contain 0-40% of nonionic surfactant such as alcohol ethoxylate (AEO or AE), alcohol propoxylate, carboxylated alcohol ethoxylates, nonylphenol ethoxylate, alkylpolyglycoside, alkyldimethylamine oxide, ethoxylated fatty acid monoethanolamide, fatty acid monoethanolamide, or polyhydroxy alkyl fatty acid amide (e.g. as described in WO 92/06154).
The detergent composition may additionally comprise one or more other enzymes, such as pullulanase, esterase, lipase, cutinase, protease, cellulase, or peroxidase.
Normally the detergent contains 1-65% of a detergent builder, but some dishwashing detergents may contain even up to 90% of a detergent builder, or complexing agent such as zeolite, diphosphate, triphosphate, phosphonate, citrate, nitrilotriacetic acid (NTA), ethylenediaminetetraacetic acid
(EDTA), diethylenetriaminepentaacetic acid (DTMPA), alkyl- or alkenylsuccinic acid, soluble silicates or layered silicates
(e.g. SKS-6 from Hoechst).
The detergent builders may be subdivided into phosphorus-containing and non-phosphorous-containing types.
Examples of phosphorus-containing inorganic alkaline detergent builders include the water-soluble salts, especially alkali metal pyrophosphates, orthophosphates, polyphosphates and phosphonates. Examples of non-phosphorus-containing inorganic builders include water-soluble alkali metal carbonates, borates and silicates as well as layered disilicates and the various types of water-insoluble crystalline or amorphous alumino silicates of which zeolites is the best known representative.
Examples of suitable organic builders include alkali metal, ammonium or substituted ammonium salts of succinates, malonates, fatty acid malonates, fatty acid sulphonates, carboxymethoxy succinates, polyacetates, carboxylates, polycarboxylates, aminopolycarboxylates and polyacetyl carboxylates.
The detergent may also be unbuilt, i.e. essentially free of detergent builder.
The detergent may comprise one or more polymers. Examples are carboxymethylcellulose (CMC), poly(vinylpyrrolidone) (PVP), polyethyleneglycol (PEG), poly(vinyl alcohol) (PVA), polycarboxylates such as polyacrylates, polymaleates, maleic/acrylic acid copolymers and lauryl methacrylate/acrylic acid copolymers.
The detergent composition may additionally contain other bleaching agents of the chlorine/bromine-type or the oxygen-type. The bleaching agents may be coated or encapsulated. Examples of inorganic chlorine/bromine-type bleaches are lithium, sodium or calcium hypochlorite or hypobromite as well as chlorinated trisodium phosphate.
Examples of organic chlorine/bromine-type bleaches are heterocyclic N-bromo and N-chloro imides such as trichloroisocyanuric, tribromoisocyanuric, dibromoisocyanuric and dichloroisocyanuric acids, and salts thereof with water solubilizing cations such as potassium and sodium. Hydantoin compounds are also suitable. The bleaching system may also comprise peroxyacids of, e.g., the amide, imide, or sulfone type.
In dishwashing detergents the oxygen bleaches are preferred, for example in the form of an inorganic persalt, preferably with a bleach precursor or as a peroxy acid compound. Typical examples of suitable peroxy bleach compounds are alkali metal perborates, both tetrahydrates and monohydrates, alkali metal percarbonates, persilicates and perphosphates. Preferred activator materials are TAED or NOBS.
The enzymes of the detergent composition of the invention may be stabilized using conventional stabilizing agents, e.g. a polyol such as propylene glycol or glycerol, a sugar or sugar alcohol, lactic acid, boric acid, or a boric acid derivative such as, e.g., an aromatic borate ester, and the composition may be formulated as described in, e.g., WO 92/19709 and WO 92/19708. The enzymes of the invention may also be stabilized by adding reversible enzyme inhibitors, e.g., of the protein type as described in EP 0 544 777 B1.
The detergent may also contain other conventional detergent ingredients such as, e.g., fabric conditioners including clays, deflocculant material, foam boosters/foam depressors (in dishwashing detergents foam depressors), suds suppressors, anti-corrosion agents, soil-suspending agents, anti-soil-redeposition agents, dyes, dehydrating agents, bactericides, optical brighteners, or perfume.
The pH (measured in aqueous solution at use concentration) will usually be neutral or alkaline, e.g. in the range of 7-11.
Particular forms of laundry detergent compositions within the scope of the invention include:
1) A detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
Figure imgf000020_0001
2) A detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
Figure imgf000020_0002
Figure imgf000021_0001
3) A detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
Figure imgf000021_0002
4) A detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
Figure imgf000022_0001
5) An aqueous liquid detergent composition comprising
Figure imgf000022_0002
Figure imgf000023_0001
6) An aqueous structured liquid detergent composition comprising
Figure imgf000023_0002
7) A detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
Figure imgf000023_0003
Figure imgf000024_0001
8) A detergent composition formulated as a granulate comprising
Figure imgf000024_0002
9) A detergent composition formulated as a granulate comprising
Figure imgf000024_0003
Figure imgf000025_0001
10) An aqueous liquid detergent composition comprising
Figure imgf000025_0002
11) An aqueous liquid detergent composition comprising
Figure imgf000026_0001
12) A detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
Figure imgf000026_0002
Figure imgf000027_0001
13) Detergent formulations as described in 1) - 12) wherein all or part of the linear alkylbenzenesulfonate is replaced by (C12- C18) alkyl sulfate.
14) A detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
Figure imgf000027_0002
15) A detergent composition formulated as a granulate having a bulk density of at least 600 g/l comprising
Figure imgf000027_0003
Figure imgf000028_0001
16) Detergent formulations as described in 1) - 15) which contain a stabilized or encapsulated peracid, either as an additional component or as a substitute for already specified bleach systems.
17) Detergent compositions as described in 1), 3), 7), 9) and 12) wherein perborate is replaced by percarbonate.
18) Detergent compositions as described in 1), 3), 7), 9), 12), 14) and 15) which additionally contain a manganese catalyst. The manganese catalyst may, e.g., be one of the compounds described in "Efficient manganese catalysts for low-temperature bleaching", Nature 369, 1994, pp. 637-639.
19) Detergent composition formulated as a nonaqueous detergent liquid comprising a liquid nonionic surfactant such as, e.g., linear alkoxylated primary alcohol, a builder system (e.g. phosphate), enzyme and alkali. The detergent may also comprise anionic surfactant and/or a bleach system.
Particular forms of dishwashing detergent compositions within the scope of the invention include: 1) POWDER AUTOMATIC DISHWASHING COMPOSITION
Figure imgf000029_0001
2) POWDER AUTOMATIC DISHWASHING COMPOSITION
Figure imgf000029_0002
3) POWDER AUTOMATIC DISHWASHING COMPOSITION
Figure imgf000029_0003
Figure imgf000030_0001
4) POWDER AUTOMATIC DISHWASHING COMPOSITION
Figure imgf000030_0002
5) POWDER AUTOMATIC DISHWASHING COMPOSITION
Figure imgf000030_0003
Figure imgf000031_0001
6) POWDER AND LIQUID DISHWASHING COMPOSITION WITH CLEANING SURFACTANT SYSTEM
Figure imgf000031_0002
Figure imgf000032_0001
7) NON-AQUEOUS LIQUID AUTOMATIC DISHWASHING COMPOSITION
Figure imgf000032_0002
8) NON-AQUEOUS LIQUID DISHWASHING COMPOSITION
Figure imgf000032_0003
Figure imgf000033_0001
9) THIXOTROPIC LIQUID AUTOMATIC DISHWASHING COMPOSITION
Figure imgf000033_0002
10) LIQUID AUTOMATIC DISHWASHING COMPOSITION
Figure imgf000033_0003
Figure imgf000034_0001
11) LIQUID AUTOMATIC DISHWASHING COMPOSITION CONTAINING PROTECTED BLEACH PARTICLES
Figure imgf000034_0002
11) Automatic dishwashing compositions as described in 1), 2), 3), 4), 6) and 10), wherein perborate is replaced by percarbonate.
12) Automatic dishwashing compositions as described in 1) - 6) which additionally contain a manganese catalyst. The manganese catalyst may, e.g., be one of the compounds described in "Efficient manganese catalysts for low-temperature bleaching", Nature 369, 1994, pp. 637-639.
The glucose oxidase of the invention may be incorporated in concentrations conventionally employed in detergents. It is at present contemplated that, in the detergent composition of the invention, the glucose oxidase may be added in an amount corresponding to 0.00001-1 mg (calculated as pure enzyme protein) of glucose oxidase per liter of wash/dishwash liquor. The present invention is further illustrated in the following examples which are not intended to be in any way limiting to the scope of the invention as claimed.
EXAMPLE 1 Glucose Oxidase from Cladosporium oxysporum.
The glucose oxidase of the invention may be produced by the method described in this example.
Fermentation:
The glucose oxidase producing strain, e.g., Cladosporium oxysporum, CBS 163.94, was inoculated on agar plates containing a medium of the following composition:
Yeast extract, Difco 4 g/l
K2HPO4 1 g/l
MgSO4 0.5 g/l
Glucose 15 g/l
Distilled water 1000 ml
Agar, Merck 15 g/l
pH adjustment to 7.2.
Growth at 26°C for 9 days.
The agar was cut into pieces and transferred aseptically to shake flasks, each flask containing 100 ml of inoculation medium of the following composition:
Cornsteep liquor 24 g/l
Glucose 24 g/l
Water ad 1000 ml, pH adjustment to pH 5.5. soybeanoil 0.5 ml/100 ml medium
CaCO3 0.5 g/100 ml medium
The flasks were incubated on a rotary shaker at 250 rpm, at 26°C, for 24 hours. The contents of these flasks were used for the inoculation of the production flasks which contained the following production medium (100 ml per flask): NaNO3 3 g/l
KH2PO4 1 g/l
MgSOA, 7H2O 0.5 g/l
KCl 0.5 g/l
FeSO4, 7H2O, 1% 1 ml/l
Sucrose 30 g/l
Yeast extract 5 g/l
Distilled water 1000 ml
Pluronic 0.1 ml/l
pH adjustment to pH 6.4.
Growth at 26°C, 60 hours, 250 rpm.
Using the above described method a culture of Cladosporium oxysporum, CBS 163.94, gave a fermentation result of 5 UNITS/ml. Purification and Characterization:
After separation of the solid material by centrifugation the glucose oxidase was filtrated and concentrated using a Filtron™ ultrafiltration module with a 10 kDa cut off membrane and filtrated again. The enzyme solution was then purified by hydrophobic interaction using the following conditions:
Temperature: 25°C
pH: 5.0 (adjusted with H3PO4)
Addition of salt 32.5% (w/w) (NH4)2SO4
Stirring: 30 min.
Centrifugation: Heraeus Sepatech Varifuge 20 RS
12000 × g; 30 min.; 25°C
(Precipitation discarded)
Resin; Phenyl Sepharose CL-4B equilibrated with
30% (w/w) (NH4)2SO4
Addition of resin 1.0 g (dry sucked) /5.0 g supernatant Stirring: 30 min followed by dry suction
Wash of resin: 30% (w/w) (NH4)2SO4 6-10 ml/g resin
Stirring: 15 min. followed by dry suction
Elution: Piperazine 20 mM pH 5.0 (HCl) 3-5 ml/g resm
Stirring: 30 min. followed by dry suction
Elution: Repeated as described above.
After hydrophobic interaction purification the glucose oxidase solution was ultrafiltrated again, this time using a 20 kDa cut off membrane. Finally a ionexchange chromatography purification took place using a Pharmacia LKB HPLC/25°C system using piperazine as buffer.
Yield: a supernatant of 2850 ml gave a final solution (after purification) of 30 ml, corresponding to approximately 53 mg glucose oxidase protein (A200).
The MW and the pi of the glucose oxidase were estimated to 90-100 kDa (SDS-PAGE) and 4.1-4.3 (IEF) respectively. The found molecular weight (MW) may be that of a subunit (monomer). pH Profile: The pH profile was performed using a glucose oxidase preparation which after fermentation as described above was ultrafiltrated using a 10 kDa cut off membrane and then precipitated with ethanol 55% (w/w) whereafter it was ultrafiltrated again resulting in a preparation with an activity of 200 UNITS/ml. The preparation was used to determine the pH profile previously described in this specification.
EXAMPLE 2
Glucose Oxidase from C. oxysporum for Gluten Strengthening
The dynamic shear storage modulus G' and the viscoelastic phase angle δ (defined as previously described) were measured in the gluten from 4 doughs, which were treated with different conditioners. The conditioners were added to the flour before dough mixing. The gluten was washed out of the flour dough containing the conditioner after the flour dough had been incubated at 32°C for 1M hours. The results of the tests are presented in Figs. 2 and 3. The following symbols were used:
□: a dough with no added conditioner (= reference);
∇: a dough containing 20 ppm KBrO3. KBrO3 is a traditional dough conditioner;
♢: a dough containing 500 UNITS per kg of flour of a glucose oxidase from A. niger;
Δ: a dough containing 500 UNITS per kg of flour of a glucose oxidase of the invention, obtained as described in Example 1;
It can be seen from Fig. 2 that surprisingly the storage modulus G' of the gluten treated with the glucose oxidase of the invention is significantly higher than the G' of the gluten treated with the traditional glucose oxidase, dosed with the same amount of units, and also higher than the G' of the traditional dough conditioner KBrO3. This result suggests that the gluten, thereby the dough, is significantly strengthened by addition of the glucose oxidase of the invention.
Fig. 3 shows that the traditional dough conditioner KBrO3 as expected lowers the phase angle δ compared to the reference with no added conditioner; this indicates a more elastic rheological property. This decrease in phase angle is also found with the traditional glucose oxidase from A. niger. However, when using the glucose oxidase of the invention the phase angle δ is decreased even more when compared with the traditional conditioners.
The above demonstrated effects of the glucose oxidase of the invention can also be found when additionally glucose is added to the dough.
EXAMPLE 3 Baking Trial
Recipe (wheat flour pan bread):
Wheat flour 100 %
Yeast 2.5 % Salt 2 %
Sugar 1 %
Water 54.5 %
Flour type: Flour without ascorbic acid (Intermill, Schweiz). Preparation of bread, procedure:
1. Dough mixing (Spiral mixer)
3 min. at 700 RPM
6 min. at 1400 RPM
the mixing time was determined and adjusted by a skilled baker so as to obtain an optimum dough consistence under the testing conditions used.
2. Fermentation 28°C - 60% RH, 40 min.
3. Sheeting, moulding and panning.
4. Fermentation 32°C - 80% RH, 70 min.
5. Baking: 230°C, 35 min.
Evaluation of Dough and Baked Bread
Dough and baked breads described in this example were evaluated as follows:
Loaf specific volume: The mean value of 4 loaves volume were measured using the traditional rape seed method. The specific volume was calculated as volume ml per g bread. The specific volume of the control (without enzyme) was defined as 100. The relative specific volume index was calculated as:
Figure imgf000039_0001
The dough stickiness, firmness, extensibility, elasticity and flavour as well as the colour/crust crispy/crumb structure of the breads were evaluated according to the following score system: Dough Stickiness: almost liquid 1 too sticky 2 sticky 3 normal 4 dry 5
Dough Firmness: very soft 1 too soft 2 soft/good 3 normal 4 firm 5 too firm 6
Dough Extensibility: very short 1 short 2 normal 3 good 4 long 5 too long 6
Dough Elasticity: very strong 1 strong 2 normal 3 good 4 weak 5 too weak 6
Dough Flavour: less 2 normal 3 good 4
Bread Colour: very light 1 light 2 normal 3 good 4 very good 5
too dark 6
Crust Crispy: too rubbery 1
rubbery 2
normal 3
good/crispy 4
very good 5
too crispy 6
Crumb Structure: very poor 1
poor 2
non-uniform 3
uniform/good 4
very good 5
Shock test: After the second fermentation the breads were exposed to an over fermentation of 10 min., 32°C, 80% RH, (i.e. for these breads the second fermentation lasted 80 min. in all), whereafter a pan containing the dough was dropped from a height of 20 cm. The dough was then baked (225°C, 30 min.) and the volume of the resulting bread was determined.
It can be seen from Table 1 that glucose oxidase showed good effects on dough consistency such as decreased stickiness and improved firmness thereby strengthening the gluten net and thereby improving the stability.
Figure imgf000042_0001
It can be seen from Table 2 that glucose oxidase of the invention has a significant effect on improving the baking quality of flour. The specific volume increased between 10% to 20%, and the breads also performed very well after shock test. The colour, the crust crispy and the crumb structure were also improved after adding glucose oxidase, only the crumb structure did not perform so satisfactory if the glucose oxidase is dosed higher than 400-500 UNITS per kg flour.
Figure imgf000043_0001
Figure imgf000044_0001
Figure imgf000045_0001

Claims

1. A glucose oxidase characterized by:
(a) A pH-optimum in the range pH 6-7, having more than 75% of maximum activity at pH 8, determined at 30°C with D-glucose as substrate.
2. A glucose oxidase according to claim 1, characterized by displaying immunochemical cross-reactivity with an antibody raised against a glucose oxidase obtainable from a strain of the genus Cladosporium.
3. A glucose oxidase according to claim 2, wherein said glucose oxidase is obtainable from a strain of Cladosporium oxysporum.
4. A glucose oxidase according to either of claims 2-3, wherein said glucose oxidase is obtainable from the strain Cladosporium oxysporum, CBS 163.94.
5. A glucose oxidase according to any of claims 1-4, comprising the following amino acid sequence in the N-terminal: Ala-Ser-Pro-Ala-Glu-Pro-Pro-Val-Val-Ala-Ala (SEQ ID No. 1) or a glucose oxidase being at least 70% homologous with the amino acid sequence (SEQ ID No. 1) in the N-terminal.
6. A process for the production of glucose oxidase, characterized by comprising cultivation in a suitable nutrient medium of a glucose oxidase producing strain of Cladosporium oxysporum, preferably CBS 163.94.
7. A process according to claim 6, wherein said cultivation is performed at a temperature in the range 20-30°C.
8. A bleaching composition comprising a glucose oxidase according to claims 1-5 and a substrate for the glucose oxidase .
9. A bleaching composition according to claim 8, which additionally comprises a peroxidase.
10. A bleaching composition according to claim 9, which additionally comprises an oxidizable substrate such as an organic compound, such as a phenolic compound, such as p-hydroxybenzenesulfonic acid.
11. A detergent composition comprising a surfactant, a glucose oxidase according to any of claims 1-5 and a substrate for the glucose oxidase.
12. A detergent composition according to claim 11, which additionally comprises a peroxidase.
13. A detergent composition according to claim 12, which additionally comprises an oxidizable substrate such as an organic compound, such as a phenolic compound, such as p-hydroxybenzenesulfonic acid.
14. A dough conditioner or bread-improving composition comprising a glucose oxidase according to any of claims 1-5.
15. A pre-mix for baked products which comprises a glucose oxidase according to any of claims 1-5.
16. Use of a glucose oxidase according to any of claims 1-5 for improving properties of a dough and/or a baked product made from a dough.
17. Use of a glucose oxidase according to any of claims 1-5 for improving properties of gluten.
18. Use of a glucose oxidase according to any of claims 1-5 for a personal care product.
19. A DNA construct comprising a DNA sequence encoding a glucose oxidase according to any one of claims 1-5.
20. A recombinant expression vector which carries a
DNA construct according to claim 19.
21. A cell which is transformed with a DNA construct according to claim 18 or a vector according to claim 20.
22. A cell according to claim 21, which is a microorganism.
23. A cell according to claim 22, which is a bacterium or a fungus.
24. A method of producing a glucose oxidase according to any one of claims 1-5, wherein a cell according to any one of claims 21-23 is cultured under conditions conducive to the production of the glucose oxidase and the glucose oxidase is subsequently recovered from the culture.
PCT/DK1995/000178 1994-05-03 1995-05-03 Alkaline glucose oxidase WO1995029996A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP95918541A EP0758377A1 (en) 1994-05-03 1995-05-03 Alkaline glucose oxidase
AU24450/95A AU695391B2 (en) 1994-05-03 1995-05-03 Alkaline glucose oxidase
US08/446,645 US5741688A (en) 1994-05-03 1995-05-03 Alkaline glucose oxidase obtained from cladosporium oxysporum
US08/746,283 US5834280A (en) 1994-05-03 1996-11-07 Glucose oxidases obtained from a cladosporium

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK504/94 1994-05-03
DK50494 1994-05-03

Publications (1)

Publication Number Publication Date
WO1995029996A1 true WO1995029996A1 (en) 1995-11-09

Family

ID=8094315

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1995/000178 WO1995029996A1 (en) 1994-05-03 1995-05-03 Alkaline glucose oxidase

Country Status (5)

Country Link
US (1) US5741688A (en)
EP (1) EP0758377A1 (en)
AU (1) AU695391B2 (en)
CA (1) CA2189542A1 (en)
WO (1) WO1995029996A1 (en)

Cited By (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998020136A1 (en) * 1996-11-07 1998-05-14 Novo Nordisk Biotech, Inc. Glucose oxidases
WO1998056885A2 (en) * 1997-06-13 1998-12-17 Unilever N.V. Bleaching enzymes
WO1999003351A1 (en) * 1997-07-18 1999-01-28 Danisco A/S A composition comprising an enzyme having galactose oxidase activity and use thereof
US5976397A (en) * 1996-09-26 1999-11-02 Lever Brothers Company Photofading inhibitor derivatives and their use in fabric treatment compositions
EP1065259A1 (en) * 1999-07-01 2001-01-03 The Procter & Gamble Company Detergent compositions comprising an amyloglucosidase enzyme
EP1065261A2 (en) * 1999-07-01 2001-01-03 The Procter & Gamble Company Detergent compositions comprising a retrograded starch degrading enzyme
EP1065260A1 (en) * 1999-07-01 2001-01-03 The Procter & Gamble Company Detergent compositions comprising a raw starch degrading enzyme
US6251626B1 (en) 1995-06-07 2001-06-26 Bioteknologisk Institut Recombinant hexose oxidase, a method of producing same and use of such enzyme
WO2002030207A1 (en) * 2000-10-12 2002-04-18 Novozymes A/S Preparation of baked product from dough
US6852346B2 (en) 1997-04-09 2005-02-08 Danisco A/S Method for preparing flour doughs and products made from such doughs using lipase
US6929936B1 (en) 1997-07-18 2005-08-16 Danisco A/S Composition comprising an enzyme having galactose oxidase activity and use thereof
WO2008017668A1 (en) * 2006-08-09 2008-02-14 Henkel Ag & Co. Kgaa Washing and cleaning agent containing oxidoreductases and bleach activators
US7745599B1 (en) 1995-06-07 2010-06-29 Danisco A/S Hexose oxidase-encoding DNAs and methods of use thereof
WO2010115735A2 (en) 2009-04-03 2010-10-14 Novozymes A/S Methods for inactivating viruses
WO2010122100A1 (en) 2009-04-22 2010-10-28 Novozymes A/S Methods for killing or inhibiting growth of mycobacteria
EP2258836A1 (en) 2004-09-10 2010-12-08 Novozymes North America, Inc. Methods for preventing, removing, reducing, or disrupting biofilm
WO2011120938A2 (en) 2010-03-28 2011-10-06 Novozymes A/S Enzymatic hydroxylation of aliphatic hydrocarbon
WO2012001145A1 (en) 2010-07-01 2012-01-05 Novozymes A/S Bleaching of pulp
USRE43135E1 (en) 2001-05-18 2012-01-24 Danisco A/S Method of improving dough and bread quality
EP2415863A1 (en) 2010-08-03 2012-02-08 B.R.A.I.N. Mutant glucose oxidase
WO2012038466A1 (en) 2010-09-21 2012-03-29 Novozymes A/S Removal of selenocyanate or selenite from aqueous solutions
USRE43341E1 (en) 1995-06-07 2012-05-01 Danisco A/S Method of improving the properties of a flour dough, a flour dough improving composition and improved food products
US8178090B2 (en) 1995-06-07 2012-05-15 Danisco A/S Recombinant hexose oxidase
WO2013004639A2 (en) 2011-07-07 2013-01-10 Novozymes A/S Enzymatic preparation of diols
WO2013021059A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021062A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021061A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021065A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021064A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021060A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021063A2 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013040991A1 (en) 2011-09-23 2013-03-28 Novozymes A/S Color modification of textile
WO2013079533A1 (en) 2011-12-02 2013-06-06 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013079531A2 (en) 2011-12-02 2013-06-06 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013144105A1 (en) 2012-03-31 2013-10-03 Novozymes A/S Epoxidation using peroxygenase
WO2013164429A1 (en) 2012-05-02 2013-11-07 Novozymes A/S Enzymatic solubilization of metals
WO2014015256A2 (en) 2012-07-20 2014-01-23 Novozymes A/S Enzymatic oxidation of 5-hydroxymethylfurfural and derivatives thereof
WO2014056916A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056927A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056919A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056922A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056920A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056917A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056921A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014090940A1 (en) 2012-12-14 2014-06-19 Novozymes A/S Removal of skin-derived body soils
WO2014114810A1 (en) 2013-01-28 2014-07-31 Roche Diagnostics Gmbh Novel glucose oxidases derived from aspergillus niger
WO2014122109A1 (en) 2013-02-05 2014-08-14 Novozymes A/S Enzymatic preparation of indigo dyes and intermediates
EP2796547A1 (en) 2013-04-24 2014-10-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Novel glucose oxidase variants
US8889371B2 (en) 2004-07-16 2014-11-18 Dupont Nutrition Biosciences Aps Lipolytic enzyme: uses thereof in the food industry
WO2015079064A2 (en) 2013-11-29 2015-06-04 Novozymes A/S Peroxygenase variants
WO2016007309A1 (en) 2014-07-07 2016-01-14 Novozymes A/S Use of prehydrolysate liquor in engineered wood
WO2016207373A1 (en) 2015-06-26 2016-12-29 Novozymes A/S Polypeptides having peroxygenase activity
WO2018002379A2 (en) 2016-07-01 2018-01-04 Novozymes A/S Enzymatic preparation of indigo dyes and in situ dyeing process
WO2018184818A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
WO2018206553A1 (en) 2017-05-09 2018-11-15 Novozymes A/S Animal chew toy with dental care composition
WO2021239950A1 (en) 2020-05-29 2021-12-02 Novozymes A/S Method for controlling slime in a pulp or paper making process
WO2022066007A1 (en) 2020-09-23 2022-03-31 Gecco Biotech B.V. Bacterial unspecific peroxygenases (bupo's) and methods and uses thereof
WO2022263553A1 (en) 2021-06-16 2022-12-22 Novozymes A/S Method for controlling slime in a pulp or paper making process
WO2023003464A1 (en) 2021-07-20 2023-01-26 Gecco Biotech B.V. Methods for oxyfunctionalization of various substrates using bacterial enzymes.

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4750597A1 (en) 1995-06-07 1999-03-31 Danisco METHOD AND COMPOSITION TO IMPROVE THE FLOUR MASS.
CN1315455C (en) * 1995-08-18 2007-05-16 诺沃奇梅兹有限公司 Tooth bleaching
ATE227844T1 (en) 1997-02-06 2002-11-15 Therasense Inc SMALL VOLUME SENSOR FOR IN-VITRO DETERMINATION
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US6251260B1 (en) 1998-08-24 2001-06-26 Therasense, Inc. Potentiometric sensors for analytic determination
US6338790B1 (en) 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6591125B1 (en) 2000-06-27 2003-07-08 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
EP1192269A2 (en) 1999-06-18 2002-04-03 Therasense, Inc. MASS TRANSPORT LIMITED i IN VIVO /i ANALYTE SENSOR
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
EP1397068A2 (en) 2001-04-02 2004-03-17 Therasense, Inc. Blood glucose tracking apparatus and methods
AU2003303597A1 (en) 2002-12-31 2004-07-29 Therasense, Inc. Continuous glucose monitoring system and methods of use
MXPA05007654A (en) 2003-01-17 2005-09-30 Danisco Method.
US7587287B2 (en) 2003-04-04 2009-09-08 Abbott Diabetes Care Inc. Method and system for transferring analyte test data
US7252850B2 (en) * 2003-05-30 2007-08-07 Delavau Llc High protein and high fiber food products
US8066639B2 (en) 2003-06-10 2011-11-29 Abbott Diabetes Care Inc. Glucose measuring device for use in personal area network
US7306641B2 (en) * 2003-09-12 2007-12-11 Hewlett-Packard Development Company, L.P. Integral fuel cartridge and filter
EP1718198A4 (en) 2004-02-17 2008-06-04 Therasense Inc Method and system for providing data communication in continuous glucose monitoring and management system
GB0415905D0 (en) * 2004-07-16 2004-08-18 Reckitt Benckiser Nv Enzymes as active oxygen generators in cleaning compositions
US8112240B2 (en) 2005-04-29 2012-02-07 Abbott Diabetes Care Inc. Method and apparatus for providing leak detection in data monitoring and management systems
US7766829B2 (en) 2005-11-04 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing basal profile modification in analyte monitoring and management systems
US7885698B2 (en) 2006-02-28 2011-02-08 Abbott Diabetes Care Inc. Method and system for providing continuous calibration of implantable analyte sensors
US7620438B2 (en) 2006-03-31 2009-11-17 Abbott Diabetes Care Inc. Method and system for powering an electronic device
US8226891B2 (en) 2006-03-31 2012-07-24 Abbott Diabetes Care Inc. Analyte monitoring devices and methods therefor
US7920907B2 (en) 2006-06-07 2011-04-05 Abbott Diabetes Care Inc. Analyte monitoring system and method
US8930203B2 (en) 2007-02-18 2015-01-06 Abbott Diabetes Care Inc. Multi-function analyte test device and methods therefor
US8732188B2 (en) 2007-02-18 2014-05-20 Abbott Diabetes Care Inc. Method and system for providing contextual based medication dosage determination
US8123686B2 (en) 2007-03-01 2012-02-28 Abbott Diabetes Care Inc. Method and apparatus for providing rolling data in communication systems
US8461985B2 (en) 2007-05-08 2013-06-11 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US7928850B2 (en) 2007-05-08 2011-04-19 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8456301B2 (en) 2007-05-08 2013-06-04 Abbott Diabetes Care Inc. Analyte monitoring system and methods
US8665091B2 (en) 2007-05-08 2014-03-04 Abbott Diabetes Care Inc. Method and device for determining elapsed sensor life
US8103456B2 (en) 2009-01-29 2012-01-24 Abbott Diabetes Care Inc. Method and device for early signal attenuation detection using blood glucose measurements
US20100213057A1 (en) 2009-02-26 2010-08-26 Benjamin Feldman Self-Powered Analyte Sensor
US9226701B2 (en) 2009-04-28 2016-01-05 Abbott Diabetes Care Inc. Error detection in critical repeating data in a wireless sensor system
WO2010138856A1 (en) 2009-05-29 2010-12-02 Abbott Diabetes Care Inc. Medical device antenna systems having external antenna configurations
WO2011026148A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte monitoring system and methods for managing power and noise
WO2011026147A1 (en) 2009-08-31 2011-03-03 Abbott Diabetes Care Inc. Analyte signal processing device and methods
US9320461B2 (en) 2009-09-29 2016-04-26 Abbott Diabetes Care Inc. Method and apparatus for providing notification function in analyte monitoring systems
DE102010039814A1 (en) * 2010-08-26 2012-03-01 Henkel Ag & Co. Kgaa Enzyme-containing machine dishwashing detergent
JP6443802B2 (en) 2011-11-07 2018-12-26 アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. Analyte monitoring apparatus and method
US9968306B2 (en) 2012-09-17 2018-05-15 Abbott Diabetes Care Inc. Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems
US20170265483A1 (en) * 2014-08-21 2017-09-21 Dsm Ip Assets B.V. Use of penicillium glucose oxidase in the baking industry for replacing bromate or azodicarbonamide
MA46990A (en) 2017-08-24 2019-05-01 Novo Nordisk As COMPOSITIONS OF GLP-1 AND THEIR USES
CN108034642B (en) * 2017-11-13 2020-12-11 中国农业科学院北京畜牧兽医研究所 Glucose oxidase CnGOD19 and improved enzyme, gene and application thereof
CN110358688B (en) * 2019-07-04 2022-07-12 河南省科学院生物研究所有限责任公司 Extracellular glucose oxidase producing strain CY-12 and application thereof
BR112022013746A2 (en) 2020-02-18 2022-10-11 Novo Nordisk As CAGRILINTIDE AQUEOUS FORMULATION, SEMAGLUTIDE AQUEOUS FORMULATION, MEDICAL DEVICE, AND, FIXED DOSE COMBINATION

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0338452A1 (en) * 1988-04-22 1989-10-25 Gist-Brocades N.V. A method of improving the properties of dough and the quality of bread
US5288746A (en) * 1992-12-21 1994-02-22 The Procter & Gamble Company Liquid laundry detergents containing stabilized glucose/glucose oxidase as H2 O2 generation system

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4045296A (en) * 1972-08-09 1977-08-30 Beckman Instruments, Inc. Rate sensing batch analysis method and enzyme used therein

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0338452A1 (en) * 1988-04-22 1989-10-25 Gist-Brocades N.V. A method of improving the properties of dough and the quality of bread
US5288746A (en) * 1992-12-21 1994-02-22 The Procter & Gamble Company Liquid laundry detergents containing stabilized glucose/glucose oxidase as H2 O2 generation system

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DIALOG INFORMATION SERVICE, File 351, World Patent Index 89-94, Dialog Accession No. 009937307, WPI Accession No. 94-205019/25, OJI PAPER CO, "Alkali-Resistant Pyranose Oxidase prodn. - Comprises Culturing Coriolus Genus Esp. Coriolus Hirsutus IFO-4917 Strain"; & JP,A,06 141 854, 24-05-94, 9425, (Basic). *

Cited By (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544795B2 (en) 1995-06-07 2009-06-09 Danisco A/S Recombinant hexose oxidase, a method of producing same and use of such enzyme
US7745599B1 (en) 1995-06-07 2010-06-29 Danisco A/S Hexose oxidase-encoding DNAs and methods of use thereof
US6251626B1 (en) 1995-06-07 2001-06-26 Bioteknologisk Institut Recombinant hexose oxidase, a method of producing same and use of such enzyme
US7727572B2 (en) 1995-06-07 2010-06-01 Danisco A/S Recombinant hexose oxidase, a method of producing same and use of such enzyme
US8178090B2 (en) 1995-06-07 2012-05-15 Danisco A/S Recombinant hexose oxidase
US8338153B2 (en) 1995-06-07 2012-12-25 Dupont Nutrition Biosciences Aps Recombinant hexose oxidase, a method of producing same and use of such enzyme
USRE43341E1 (en) 1995-06-07 2012-05-01 Danisco A/S Method of improving the properties of a flour dough, a flour dough improving composition and improved food products
US5976397A (en) * 1996-09-26 1999-11-02 Lever Brothers Company Photofading inhibitor derivatives and their use in fabric treatment compositions
WO1998020136A1 (en) * 1996-11-07 1998-05-14 Novo Nordisk Biotech, Inc. Glucose oxidases
US5879921A (en) * 1996-11-07 1999-03-09 Novo Nordisk A/S Recombinant expression of a glucose oxidase from a cladosporium strain
US6852346B2 (en) 1997-04-09 2005-02-08 Danisco A/S Method for preparing flour doughs and products made from such doughs using lipase
WO1998056885A3 (en) * 1997-06-13 1999-03-25 Unilever Nv Bleaching enzymes
WO1998056885A2 (en) * 1997-06-13 1998-12-17 Unilever N.V. Bleaching enzymes
US6218350B1 (en) 1997-06-13 2001-04-17 Lever Brothers Company, Division Of Conopco, Inc. Bleaching enzymes
WO1999003351A1 (en) * 1997-07-18 1999-01-28 Danisco A/S A composition comprising an enzyme having galactose oxidase activity and use thereof
US6929936B1 (en) 1997-07-18 2005-08-16 Danisco A/S Composition comprising an enzyme having galactose oxidase activity and use thereof
WO2001002529A1 (en) * 1999-07-01 2001-01-11 The Procter & Gamble Company Detergent compositions comprising a raw starch degrading enzyme
EP1065260A1 (en) * 1999-07-01 2001-01-03 The Procter & Gamble Company Detergent compositions comprising a raw starch degrading enzyme
EP1065261A3 (en) * 1999-07-01 2001-04-04 The Procter & Gamble Company Detergent compositions comprising a retrograded starch degrading enzyme
WO2001002530A1 (en) * 1999-07-01 2001-01-11 The Procter & Gamble Company Detergent compositions comprising a retrograded starch degrading enzyme
WO2001002528A1 (en) * 1999-07-01 2001-01-11 The Procter & Gamble Company Detergent compositions comprising an amyloglucosidase enzyme
EP1065261A2 (en) * 1999-07-01 2001-01-03 The Procter & Gamble Company Detergent compositions comprising a retrograded starch degrading enzyme
EP1065259A1 (en) * 1999-07-01 2001-01-03 The Procter & Gamble Company Detergent compositions comprising an amyloglucosidase enzyme
US6890570B2 (en) 2000-10-12 2005-05-10 Novozymes A/S Preparation of baked product from dough
WO2002030207A1 (en) * 2000-10-12 2002-04-18 Novozymes A/S Preparation of baked product from dough
USRE43135E1 (en) 2001-05-18 2012-01-24 Danisco A/S Method of improving dough and bread quality
US8889371B2 (en) 2004-07-16 2014-11-18 Dupont Nutrition Biosciences Aps Lipolytic enzyme: uses thereof in the food industry
EP2258837A1 (en) 2004-09-10 2010-12-08 Novozymes North America, Inc. Methods for preventing, removing, reducing, or disrupting biofilm
EP2258836A1 (en) 2004-09-10 2010-12-08 Novozymes North America, Inc. Methods for preventing, removing, reducing, or disrupting biofilm
WO2008017668A1 (en) * 2006-08-09 2008-02-14 Henkel Ag & Co. Kgaa Washing and cleaning agent containing oxidoreductases and bleach activators
WO2010115735A2 (en) 2009-04-03 2010-10-14 Novozymes A/S Methods for inactivating viruses
WO2010122100A1 (en) 2009-04-22 2010-10-28 Novozymes A/S Methods for killing or inhibiting growth of mycobacteria
WO2011120938A2 (en) 2010-03-28 2011-10-06 Novozymes A/S Enzymatic hydroxylation of aliphatic hydrocarbon
WO2012001145A1 (en) 2010-07-01 2012-01-05 Novozymes A/S Bleaching of pulp
WO2012017008A1 (en) 2010-08-03 2012-02-09 B.R.A.I.N. Biotechnology Research And Information Network Ag A novel glucose oxidase
EP2415863A1 (en) 2010-08-03 2012-02-08 B.R.A.I.N. Mutant glucose oxidase
WO2012038466A1 (en) 2010-09-21 2012-03-29 Novozymes A/S Removal of selenocyanate or selenite from aqueous solutions
WO2013004639A2 (en) 2011-07-07 2013-01-10 Novozymes A/S Enzymatic preparation of diols
WO2013021062A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021061A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021065A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021064A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021060A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021063A2 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013021059A1 (en) 2011-08-10 2013-02-14 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013040991A1 (en) 2011-09-23 2013-03-28 Novozymes A/S Color modification of textile
WO2013079531A2 (en) 2011-12-02 2013-06-06 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013079533A1 (en) 2011-12-02 2013-06-06 Novozymes A/S Polypeptides having peroxygenase activity and polynucleotides encoding same
WO2013144105A1 (en) 2012-03-31 2013-10-03 Novozymes A/S Epoxidation using peroxygenase
WO2013164429A1 (en) 2012-05-02 2013-11-07 Novozymes A/S Enzymatic solubilization of metals
WO2014015256A2 (en) 2012-07-20 2014-01-23 Novozymes A/S Enzymatic oxidation of 5-hydroxymethylfurfural and derivatives thereof
WO2014056922A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056919A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056927A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056920A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056917A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056921A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014056916A2 (en) 2012-10-12 2014-04-17 Novozymes A/S Polypeptides having peroxygenase activity
WO2014090940A1 (en) 2012-12-14 2014-06-19 Novozymes A/S Removal of skin-derived body soils
WO2014114810A1 (en) 2013-01-28 2014-07-31 Roche Diagnostics Gmbh Novel glucose oxidases derived from aspergillus niger
WO2014122109A1 (en) 2013-02-05 2014-08-14 Novozymes A/S Enzymatic preparation of indigo dyes and intermediates
WO2014173822A2 (en) 2013-04-24 2014-10-30 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Novel glucose oxidase variants
EP2796547A1 (en) 2013-04-24 2014-10-29 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Novel glucose oxidase variants
WO2015079064A2 (en) 2013-11-29 2015-06-04 Novozymes A/S Peroxygenase variants
WO2016007309A1 (en) 2014-07-07 2016-01-14 Novozymes A/S Use of prehydrolysate liquor in engineered wood
WO2016207373A1 (en) 2015-06-26 2016-12-29 Novozymes A/S Polypeptides having peroxygenase activity
WO2018002379A2 (en) 2016-07-01 2018-01-04 Novozymes A/S Enzymatic preparation of indigo dyes and in situ dyeing process
WO2018184818A1 (en) 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
WO2018206553A1 (en) 2017-05-09 2018-11-15 Novozymes A/S Animal chew toy with dental care composition
WO2021239950A1 (en) 2020-05-29 2021-12-02 Novozymes A/S Method for controlling slime in a pulp or paper making process
WO2022066007A1 (en) 2020-09-23 2022-03-31 Gecco Biotech B.V. Bacterial unspecific peroxygenases (bupo's) and methods and uses thereof
WO2022263553A1 (en) 2021-06-16 2022-12-22 Novozymes A/S Method for controlling slime in a pulp or paper making process
WO2023003464A1 (en) 2021-07-20 2023-01-26 Gecco Biotech B.V. Methods for oxyfunctionalization of various substrates using bacterial enzymes.

Also Published As

Publication number Publication date
AU2445095A (en) 1995-11-29
EP0758377A1 (en) 1997-02-19
US5741688A (en) 1998-04-21
CA2189542A1 (en) 1995-11-09
AU695391B2 (en) 1998-08-13

Similar Documents

Publication Publication Date Title
AU695391B2 (en) Alkaline glucose oxidase
US5827719A (en) Enzyme with lipolytic activity
AU774156B2 (en) Glycosylated proteins having reduced allergenicity
EP1212409B1 (en) Alkaline bacillus amylase
US5879921A (en) Recombinant expression of a glucose oxidase from a cladosporium strain
US5693520A (en) Recombinant trypsin-like protease
US5856164A (en) Alkaline bacillus amylase
US5834280A (en) Glucose oxidases obtained from a cladosporium
US7781200B2 (en) Polypeptides having lipase activity and polynucleotides encoding same
CA2320759A1 (en) Alkaline bacillus amylase
MX2010013108A (en) Production of glucose from starch using alpha-amylases from bacillus subtilis.
KR20100024395A (en) Improved variants of the bacillus licheniformis alpha-amylase
MXPA96004313A (en) Amilasa de bacillus alcal
CN102361972A (en) Cal a-related acyltransferases and methods of use, thereof
CA2689635A1 (en) Variants of an alpha-amylase with improved production levels in fermentation processes
KR20100088675A (en) Variants of bacillis sp. ts-23 alpha-amylase with altered properties
JPH08509364A (en) Lipase mutant
US20070244021A1 (en) Polypeptides with perhydrolase activity
US7078213B1 (en) Alkaline Bacillus amylase
MXPA97003062A (en) An enzyme with activity lipolit

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 08446645

Country of ref document: US

AK Designated states

Kind code of ref document: A1

Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IS JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TT UA UG US UZ VN

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1995918541

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2189542

Country of ref document: CA

WWP Wipo information: published in national office

Ref document number: 1995918541

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1995918541

Country of ref document: EP